Cargando…

Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy

Detalles Bibliográficos
Autores principales:	Al Hashmi, Hani, Kaloyannidis, Panayotis, Kafnar, Solaf, Al Harbi, Salman, Shaibani, Eshrak, Mokhtar, Nihad, Abdulbaki, Manar, Al Darweesh, Mohammed, Bacal, Jenifer, Apostolidis, John, Anezi, Khalid Al
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Carden Jennings Publishing 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128922/ http://dx.doi.org/10.1016/j.bbmt.2017.12.076

Ejemplares similares

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach
por: Kaloyannidis, Panayotis, et al.
Publicado: (2021)

De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma
por: Apostolidis, John, et al.
Publicado: (2020)

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??
por: Kaloyannidis, Panayotis, et al.
Publicado: (2022)

ANTIBODY RESPONSES AND SAFETY OF THE COMMERCIALLY AVAILABLE VACCINES AGAINST SARS-COV-2 VIRUS IN ALLOGRAFTED PATIENTS: REAL WORLD DATA FROM A SINGLE CENTER
por: Kaloyannidis, Panayotis, et al.
Publicado: (2022)

Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration
por: Al-Hashmi, Hani, et al.
Publicado: (2020)

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
por: Kaloyannidis, Panayotis, et al.
Publicado: (2019)

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
por: Zulian, G. B., et al.
Publicado: (1989)

Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2020)

Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2021)

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East
por: El Fakih, Riad, et al.
Publicado: (2021)

Dental plaque associated with self-ligating brackets during the initial phase of orthodontic treatment: A 3-month preliminary study
por: Al-Anezi, Saud A
Publicado: (2014)

The effect of orthodontic bands or tubes upon periodontal status during the initial phase of orthodontic treatment
por: Al-Anezi, Saud A.
Publicado: (2015)

Evaluating the Readiness of Mobile Technology with Respect to e-Heath for Medication in Saudi Arabia: An Integrative Perspective
por: Al-Anezi, Fahad M
Publicado: (2021)

Factors influencing decision making for implementing e-health in light of the COVID-19 outbreak in Gulf Cooperation Council countries
por: Al-Anezi, Fahad M
Publicado: (2021)

Huge Colonic Granuloma of Schistosomiasis Mimicked Cancer in a 10-Years-Old Child: A Case Report
por: Alyhari, Qasem, et al.
Publicado: (2022)

PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE
por: Di Folca, S., et al.
Publicado: (2022)

Reactivity of Heteropolymolybdates and Heteropolytungstates in the Cationic Polymerization of Styrene
por: Aouissi, Ahmed, et al.
Publicado: (2010)

Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.
por: Seymour, L. K., et al.
Publicado: (1994)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin's Lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2021)

The Effect and Implication of Social Media Platforms on Plastic Cosmetic Surgery: A Cross-sectional Study in Saudi Arabia From 2021 to 2022
por: AlBahlal, Ahmed, et al.
Publicado: (2023)

Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
por: Morabito, Fortunato, et al.
Publicado: (2021)

Saudi Lymphoma Group‘s Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic
por: Alzahrani, Musa, et al.
Publicado: (2020)

Hodgkin’s Lymphoma Presenting as Multiple Cavitary Lung Lesions
por: Jain, Esha, et al.
Publicado: (2021)

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
por: Pritchard, J., et al.
Publicado: (1982)

Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Rodriguez, Tulio E., et al.
Publicado: (2016)

Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
por: Byun, Ja Min, et al.
Publicado: (2018)

Dysmenorrhea among female medical students in King Abdulaziz University: Prevalence, Predictors and outcome
por: Ibrahim, Nahla Khamis, et al.
Publicado: (2015)

Primary Thymic Hodgkin Lymphoma Coexisting with Thymoma and Myasthenia Gravis: A Case Report
por: Almuqbil, Sarah, et al.
Publicado: (2023)

The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning
por: Ursu, Sorana G., et al.
Publicado: (2023)

Occupational Exposure to Needle Stick Injuries and Hepatitis B Vaccination Coverage Among Clinical Laboratory Staff in Sana’a, Yemen: Cross-Sectional Study
por: Al-Abhar, Nabil, et al.
Publicado: (2020)

Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan.
por: Moscow, J. A., et al.
Publicado: (1993)

Lung granuloma: A clinicopathologic study of 158 cases
por: Al-Harbi, Abdullah, et al.
Publicado: (2017)

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
por: Srour, Samer A., et al.
Publicado: (2021)

Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.
por: Taylor, P. R., et al.
Publicado: (1993)

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
por: Lee, Se Ryeon, et al.
Publicado: (2019)

Multiloculated Cavitary Primary Pulmonary Hodgkin Lymphoma: Case Series
por: Aljehani, Yasser, et al.
Publicado: (2018)

Overview of Assault-Induced Trauma Presenting to a Trauma Centre in Oman
por: Al-Busaidi, Mira, et al.
Publicado: (2021)

Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan
por: Nieto, Yago, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dm671c6i9trb0tu2derss0bfc5